112 related articles for article (PubMed ID: 20090448)
1. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.
Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K
Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M
Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162
[TBL] [Abstract][Full Text] [Related]
4. Obscured bone metastases after administration of hematopoietic factor on FDG-PET.
Chhabra A; Batra K; Makler PT
Clin Nucl Med; 2006 Jun; 31(6):328-30. PubMed ID: 16714890
[TBL] [Abstract][Full Text] [Related]
5. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.
Kazama T; Swanston N; Podoloff DA; Macapinlac HA
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379
[TBL] [Abstract][Full Text] [Related]
6. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
Mayer D; Bednarczyk EM
Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579
[TBL] [Abstract][Full Text] [Related]
7. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
8. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC
Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984
[TBL] [Abstract][Full Text] [Related]
9. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT.
Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H
Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173
[TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.
Morooka M; Kubota K; Murata Y; Shibuya H; Ito K; Mochizuki M; Akashi T; Chiba T; Nomura T; Ito H; Morita T
Ann Nucl Med; 2008 Aug; 22(7):635-9. PubMed ID: 18756367
[TBL] [Abstract][Full Text] [Related]
11. Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.
Zweifel M; Stenner-Liewen F; Weber A; Samaras P; Zaugg K; Knuth A; Soyka JD
Clin Nucl Med; 2010 Feb; 35(2):103-4. PubMed ID: 20090458
[No Abstract] [Full Text] [Related]
12. G-CSF induces focal intense bone marrow FDG uptake mimicking multiple bone metastases from uterine cervical cancer: a case report and review of the literature.
Mabuchi S; Morimoto A; Fujita M; Isohashi K; Kimura T
Eur J Gynaecol Oncol; 2012; 33(3):316-7. PubMed ID: 22873109
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma.
Trout AT; Sharp SE; Turpin BK; Zhang B; Gelfand MJ
Pediatr Radiol; 2015 Jul; 45(7):1001-6. PubMed ID: 25646737
[TBL] [Abstract][Full Text] [Related]
14. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
16. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H
Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396
[TBL] [Abstract][Full Text] [Related]
17. Combined increased and decreased skeletal uptake of F-18 FDG.
Goshen E; Davidson T; Yeshurun M; Zwas ST
Clin Nucl Med; 2006 Sep; 31(9):520-2. PubMed ID: 16921273
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.
Hollinger EF; Alibazoglu H; Ali A; Green A; Lamonica G
Clin Nucl Med; 1998 Feb; 23(2):93-8. PubMed ID: 9481497
[TBL] [Abstract][Full Text] [Related]
19. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.
Sugawara Y; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Nucl Med; 1999 Sep; 40(9):1456-62. PubMed ID: 10492365
[TBL] [Abstract][Full Text] [Related]
20. [Transitory increase in splenic FDG uptake secondary to the administration of granulocyte colony stimulating factor (G-CSF)].
Ubieto MA; Banzo J
Rev Esp Med Nucl; 2009; 28(1):36. PubMed ID: 19232179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
